What is Agilon Health's 2028?

Agilon Health (AGL) reported 2028 of $24.77M in Q1 2026.

How has Agilon Health's 2028 changed year-over-year?

Agilon Health's 2028 decreased by 11.9% year-over-year, from $28.13M to $24.77M.

Revenue$1.4B-7.3%

Operating income$4.0M+118%

Net income$48.9M+304%

EPS (diluted)$2.94+303%

Cash & equivalents$211.6M+52.6%

Total debt$33.4M-20.5%

Total equity$181.4M-63.7%

Total assets$1.5B-22.1%

Operating cash flow$23.7M+174%

CapEx$3.1M-19.4%

Free cash flow$20.6M+158%

Market cap$1.78B-92.6%

Enterprise value$1.61B-103%

P/S0.3×-3.8×

Operating margin-7.5%+6.5pp

Net margin-6.1%+6.3pp

FCF margin-1.1%—

Return on equity-104%-291pp

Debt / equity0.2×+0.1×

Current ratio1×-0.2×

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept agl:DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearThree.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and see it in context, right in your chat.

What is Agilon Health's 2028?: Agilon Health (AGL) reported 2028 of $24.77M in Q1 2026.
How has Agilon Health's 2028 changed year-over-year?: Agilon Health's 2028 decreased by 11.9% year-over-year, from $28.13M to $24.77M.